Trade Gilead ^GILD

Positive Outlook Boosted Gilead Sciences (GILD) in Q1

Fluent Financial LLC Sells 3,334 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Merit Financial Group LLC Buys 9,522 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

The People-First Liver Charter

Greenfield Savings Bank Buys 159 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

NBC Securities Inc. Grows Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) CEO Daniel Patrick O'day Sells 10,000 Shares

Morgan Stanley Reaffirms Overweight on Gilead Sciences, Inc. (GILD), Citing LEN Potential

AEGON ASSET MANAGEMENT UK Plc Increases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

CGN Advisors LLC Decreases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Fulton Bank N.A. Sells 3,622 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Baker Tilly Wealth Management LLC Sells 3,273 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Biotech Sector Sets Up for Breakout, but Investors Need to See Follow-Through | Investing.com

Citi Analysts Affirm Buy Rating on Gilead Sciences (GILD) Stock

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Investors Research Corp

Douglas Lane & Associates LLC Takes Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Mechanics Bank Trust Department Grows Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV) and Gilead Sciences (GILD) | Markets Insider

The Academy of Oncology Nurse & Patient Navigators and Gilead Sciences Partner to Launch Oncology Navigation Grant Program | Morningstar

Veery Capital LLC Acquires New Position in Gilead Sciences, Inc. (NASDAQ:GILD)

2,432 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by J2 Capital Management Inc

- Long-Term Analysis Shows Similar Safety and Effectiveness

Meyer Handelman Co. Cuts Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

BTC Capital Management Inc. Lowers Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Lantz Financial LLC Lowers Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Parallel Advisors LLC Has $3.83 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by GAMMA Investing LLC

Gilead Sciences, Inc, (GILD)'s Trodelvy and Merck & Co., Inc, (MRK)'s Keytruda Cuts Breast Cancer Progression Risk by 35%

Summit Global Investments Cuts Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Farmers Trust Co. Has $5.46 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Wealth Enhancement Advisory Services LLC

Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial

NORTHAMPTON, MA / ACCESS Newswire / May 30, 2025 / Gilead Sc

Gilead Sciences Commemorated the Opening of the Bay Area Young Survivors Breast Cancer Memorial Garden | Morningstar

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Boston Common Asset Management LLC

111 Capital Takes Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Anchor Pointe Wealth Management LLC Invests $245,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

B. Riley Wealth Advisors Inc. Sells 8,087 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Transforming How Cancer Is Treated: Research Results To Be Shared at ASCO25

Talaria Asset Management Pty Ltd Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Fluent Financial LLC Takes $2.69 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)

American Trust Trims Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

WNY Asset Management LLC Reduces Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Ascent Group LLC Increases Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by GTS Securities LLC

Vermillion Wealth Management Inc. Makes New $65,000 Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Forum Financial Management LP Grows Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Peak Retirement Planning Inc. Invests $837,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

10,909 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Cache Advisors LLC

Toronto Dominion Bank Grows Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Eisenmenger Complex Treatment Market 2032: EMA, PDMA, FDA Approvals, Medication, NICE Approvals, Clinical Trials, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight | ABNewswire

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Public Employees Retirement System of Ohio

36,486 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Neo Ivy Capital Management

Vise Technologies Inc. Has $2.48 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Griffith & Werner Inc. Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Western Wealth Management LLC Sells 3,761 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (GILD)'s Breast Cancer Study Success Drives Investor Optimism Amid Broader Market Slump

Vident Advisory LLC Lowers Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Two Sigma Investments LP Sells 458,712 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead (GILD) to Acquire HOOK for $10 million

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by USS Investment Management Ltd

Gilead's ASCENT-03 Study Of Trodelvy In First-line MTNBC Meets Primary Goal

Durable response to CAR T is associated with elevated activation and clonotypic expansion of the cytotoxic native T cell repertoire

Gilead Sciences Inc. (GILD) - Insider Monkey

Vident Advisory LLC Sells 29,112 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Woodline Partners LP Sells 1,193,336 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

"The Adventure Jar" - A Children's Book Supporting Families Impacted by Metastatic Breast Cancer (MBC) Receives Two 2025 Bronze Anvil Awards

Needham & Company LLC Reaffirms Hold Rating for Gilead Sciences (NASDAQ:GILD)

Soviero Asset Management LP Sells 3,000 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Brokerages Set Gilead Sciences, Inc. (NASDAQ:GILD) Price Target at $110.55

WBI Investments LLC Raises Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Triglav Skladi D.O.O. Acquires New Shares in Gilead Sciences, Inc. (NASDAQ:GILD)

Link Between Viral Infection and Alzheimer's Emerges in New Data

Baron Discovery Fund Initiated a Position in Arcellx (ACLX)

Zurich Insurance Group Ltd FI Has $83.96 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Unusual Options Alert: The Smart Money is Piling Into Gilead Sciences (GILD)

WBI Investments LLC Increases Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Sarissa Capital Management LP Lowers Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) CFO Sells $249,550.00 in Stock

Gilead Sciences discovers new PRMT5 inhibitors | BioWorld

Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHA

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Shell Asset Management Co.

Snowden Capital Advisors LLC Lowers Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Quantinno Capital Management LP Acquires 58,305 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Sen. John Boozman Sells Gilead Sciences, Inc. (NASDAQ:GILD) Stock

Mufg Securities Americas Inc. Buys New Shares in Gilead Sciences, Inc. (NASDAQ:GILD)

Man Group plc Purchases 243,567 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Analysts

Precision Medicine Market worth $246.66 billion by 2029 with 11.1% CAGR | MarketsandMarkets™ | ABNewswire

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Increased by ProShare Advisors LLC

ProShare Advisors LLC Grows Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Point72 Asia Singapore Pte. Ltd.

Point72 Europe London LLP Sells 34,903 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Lazard Asset Management LLC

LMR Partners LLP Purchases Shares of 56,799 Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Janus Henderson Group PLC